EA026330B1 - Новые производные пиримидина в качестве ингибиторов фосфодиэстеразы 10 (pde-10) - Google Patents
Новые производные пиримидина в качестве ингибиторов фосфодиэстеразы 10 (pde-10) Download PDFInfo
- Publication number
- EA026330B1 EA026330B1 EA201591369A EA201591369A EA026330B1 EA 026330 B1 EA026330 B1 EA 026330B1 EA 201591369 A EA201591369 A EA 201591369A EA 201591369 A EA201591369 A EA 201591369A EA 026330 B1 EA026330 B1 EA 026330B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- bromo
- pyrimidin
- diamine
- group
- pyrazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201330082A ES2480341B1 (es) | 2013-01-24 | 2013-01-24 | Nuevos derivados de pirimidina como inhibidores de la fosfodiesterasa 10 (PDE-10) |
| PCT/EP2014/051290 WO2014114695A1 (en) | 2013-01-24 | 2014-01-23 | New pyrimidine derivatives as phosphodiesterase 10 inhibitors (pde-10) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201591369A1 EA201591369A1 (ru) | 2016-01-29 |
| EA026330B1 true EA026330B1 (ru) | 2017-03-31 |
Family
ID=50071592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201591369A EA026330B1 (ru) | 2013-01-24 | 2014-01-23 | Новые производные пиримидина в качестве ингибиторов фосфодиэстеразы 10 (pde-10) |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9447095B2 (enExample) |
| EP (1) | EP2948443B1 (enExample) |
| JP (1) | JP6254194B2 (enExample) |
| KR (1) | KR101869144B1 (enExample) |
| CN (1) | CN105008346B (enExample) |
| AU (1) | AU2014209950B2 (enExample) |
| BR (1) | BR112015017678B1 (enExample) |
| CA (1) | CA2897260C (enExample) |
| CY (1) | CY1118552T1 (enExample) |
| DK (1) | DK2948443T3 (enExample) |
| EA (1) | EA026330B1 (enExample) |
| ES (2) | ES2480341B1 (enExample) |
| HR (1) | HRP20161495T1 (enExample) |
| HU (1) | HUE031831T2 (enExample) |
| LT (1) | LT2948443T (enExample) |
| ME (1) | ME02551B (enExample) |
| MX (1) | MX361160B (enExample) |
| PL (1) | PL2948443T3 (enExample) |
| PT (1) | PT2948443T (enExample) |
| RS (1) | RS55449B1 (enExample) |
| SI (1) | SI2948443T1 (enExample) |
| SM (1) | SMT201600428B (enExample) |
| WO (1) | WO2014114695A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017133657A1 (en) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza |
| CN107286146B (zh) * | 2017-07-05 | 2020-07-31 | 上海肇钰医药科技有限公司 | 作为腺苷a2a受体拮抗剂的4-氨基嘧啶衍生物及其用途 |
| CN116836162B (zh) * | 2023-05-24 | 2025-09-05 | 南方医科大学 | 吡唑[4,3-c]吡啶类化合物或其药学上可接受的盐及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011119518A1 (en) * | 2010-03-25 | 2011-09-29 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| WO2011121418A1 (en) * | 2010-03-31 | 2011-10-06 | Palobiofarma, S.L. | 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| WO2013052395A1 (en) * | 2011-10-06 | 2013-04-11 | Merck Sharp & Dohme Corp. | 1,3-substituted azetidine pde10 inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080221103A1 (en) | 2007-03-09 | 2008-09-11 | Orchid Research Laboratories Ltd. | New heterocyclic compounds |
| SI2617420T1 (sl) | 2009-05-07 | 2016-02-29 | Forum Pharmaceuticals Inc. | Fenoksimetil heterociklične spojine |
| WO2010138430A1 (en) | 2009-05-27 | 2010-12-02 | Merck Sharp & Dohme Corp. | Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors |
| US20120082354A1 (en) | 2009-06-24 | 2012-04-05 | Koninklijke Philips Electronics N.V. | Establishing a contour of a structure based on image information |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| NZ601967A (en) | 2010-03-12 | 2015-03-27 | Omeros Corp | Pde10 inhibitors and related compositions and methods |
| WO2011150156A2 (en) | 2010-05-26 | 2011-12-01 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| US8592423B2 (en) | 2011-06-21 | 2013-11-26 | Bristol-Myers Squibb Company | Inhibitors of PDE10 |
-
2013
- 2013-01-24 ES ES201330082A patent/ES2480341B1/es not_active Expired - Fee Related
-
2014
- 2014-01-23 EA EA201591369A patent/EA026330B1/ru not_active IP Right Cessation
- 2014-01-23 LT LTEP14703553.9T patent/LT2948443T/lt unknown
- 2014-01-23 HU HUE14703553A patent/HUE031831T2/en unknown
- 2014-01-23 HR HRP20161495TT patent/HRP20161495T1/hr unknown
- 2014-01-23 RS RS20160971A patent/RS55449B1/sr unknown
- 2014-01-23 CN CN201480006098.XA patent/CN105008346B/zh active Active
- 2014-01-23 ES ES14703553.9T patent/ES2611170T3/es active Active
- 2014-01-23 JP JP2015554139A patent/JP6254194B2/ja active Active
- 2014-01-23 MX MX2015009627A patent/MX361160B/es active IP Right Grant
- 2014-01-23 CA CA2897260A patent/CA2897260C/en active Active
- 2014-01-23 PL PL14703553T patent/PL2948443T3/pl unknown
- 2014-01-23 BR BR112015017678-0A patent/BR112015017678B1/pt active IP Right Grant
- 2014-01-23 AU AU2014209950A patent/AU2014209950B2/en active Active
- 2014-01-23 EP EP14703553.9A patent/EP2948443B1/en active Active
- 2014-01-23 PT PT147035539T patent/PT2948443T/pt unknown
- 2014-01-23 DK DK14703553.9T patent/DK2948443T3/en active
- 2014-01-23 WO PCT/EP2014/051290 patent/WO2014114695A1/en not_active Ceased
- 2014-01-23 KR KR1020157022767A patent/KR101869144B1/ko active Active
- 2014-01-23 ME MEP-2016-254A patent/ME02551B/me unknown
- 2014-01-23 SI SI201430093A patent/SI2948443T1/sl unknown
- 2014-01-24 US US14/762,655 patent/US9447095B2/en active Active
-
2016
- 2016-11-23 CY CY20161101206T patent/CY1118552T1/el unknown
- 2016-11-23 SM SM201600428T patent/SMT201600428B/it unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011119518A1 (en) * | 2010-03-25 | 2011-09-29 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| WO2011121418A1 (en) * | 2010-03-31 | 2011-10-06 | Palobiofarma, S.L. | 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| WO2013052395A1 (en) * | 2011-10-06 | 2013-04-11 | Merck Sharp & Dohme Corp. | 1,3-substituted azetidine pde10 inhibitors |
Non-Patent Citations (3)
| Title |
|---|
| GIORGI M, MELCHIORRI G, NUCCETELLI V, D'ANGELO V, MARTORANA A, SORGE R, CASTELLI V, BERNARDI G, SANCESARIO G.: "PDE10A and PDE10A-dependent cAMP catabiolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: A key step in parkinsonism physiopathology.", NEUROBIOLOGY OF DISEASE, ELSEVIER, AMSTERDAM, NL, vol. 43, no. 1, 1 July 2011 (2011-07-01), AMSTERDAM, NL, pages 293 - 303, XP002721654, ISSN: 0969-9961, DOI: 10.1016/j.nbd.2011.04.006 * |
| NISHI A, KUROIWA M, MILLER D B, O'CALLAGHAN J P, BATEUP H S, SHUTO T, SOTOGAKU N, FUKUDA T, HEINTZ N, GREENGARD P, SNYDER G L: "Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signalling in the Striatum", JOURNAL OF NEUROSCIENCE, SOCIETY FOR NEUROSCIENCE, US, vol. 28, no. 42, 15 October 2008 (2008-10-15), US, pages 10460 - 10471, XP002721653, ISSN: 0270-6474, DOI: 10.1523/JNEUROSCI.2518-08.2008 * |
| PATRICK R. VERHOEST, DOUGLAS S. CHAPIN, MICHAEL CORMAN, KARI FONSECA, JOHN F. HARMS, XINJUN HOU, ERIC S. MARR, FRANK S. MENNITI, F: "Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, UNITED STATES, vol. 52, no. 16, 24 June 2009 (2009-06-24), United States, pages 5188 - 5196, XP002721655, ISSN: 0022-2623, DOI: 10.1021/jm900521k * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102632018B1 (ko) | Fgfr 저해제로서의 이환식 복소환 | |
| KR101441781B1 (ko) | 4―아미노피리미딘 유도체 및 아데노신 ａ2ａ 수용체 안타고니스트로서의 이들의 용도 | |
| DK2452940T3 (en) | Azabicycloforbindelse and salt thereof | |
| CZ20011714A3 (cs) | Substituované pyrazoly jako inhibitory p38 kinázy | |
| US9181238B2 (en) | N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors | |
| EA007063B1 (ru) | ПРОИЗВОДНЫЕ АМИНОБЕНЗАМИДОВ В КАЧЕСТВЕ ИНГИБИТОРОВ ГЛИКОГЕНСИНТАЗА-КИНАЗЫ 3β; | |
| JP6283688B2 (ja) | カゼインキナーゼ１ｄ／ｅ阻害剤としての新規なピラゾール置換のイミダゾピラジン | |
| KR101905295B1 (ko) | 나프티리딘디온 유도체 | |
| KR20140025326A (ko) | 신규 인돌, 인다졸 유도체 또는 그 염 | |
| JP2021521178A (ja) | Ｐｉ３キナーゼおよびオートファジー経路の調節因子としての三置換アリールおよびヘテロアリール誘導体 | |
| RS65956B1 (sr) | Moćna i selektivna jedinjenja kao modulatori serotonin 1b receptora | |
| KR101869144B1 (ko) | 포스포디에스테라아제 10 억제제(pde-10)로서 신규 피리미딘 유도체 | |
| US20140288043A1 (en) | Pyrazolopyridine compounds | |
| JP2020121989A (ja) | ピリド［３，４−ｄ］ピリミジン誘導体又はその溶媒和物の結晶 | |
| JP2024528729A (ja) | Ｓｒｐｋインヒビター | |
| EP4444309A1 (en) | Pyrimidines and methods of their use | |
| BR112017025356B1 (pt) | Composto, composição farmacêutica, e, uso para a fabricação de um medicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG TJ TM |